Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Prostate Cancer (ESTO1)
NCT01821404Phase 2Completed
- Sponsor
- Tampere University Hospital
- Start
- Aug 2012
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in prostate cancer (PCa), sponsored by Tampere University Hospital. Started Aug 2012; status: completed.
02
Drugs
atorvastatin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01821404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01821404.